Polynovo Ltd has released a press release.
Pause in trading
Filed with ASX ·
On 6ix: 6ix.com/news/pause-in-trading-97
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Polynovo
- PolyNovo FY22 Briefing Session
- FY22 Results Presentation
- Appendix 4E and FY22 Financial Statements
- First Patient enrolled - SynPath Diabetic Foot Ulcer Trial
- CEO Appointment - Swami Raote
Later from Polynovo
- Trading halt
- FDA 510(k) clearance for NovoSorb MTX
- Q1 FY23 Sales Result
- Chairman and CEO - AGM address to shareholders
- Investor Presentation
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo